Contact

Email

mrd@unimelb.edu.au

Credentials

Position
Honorary Conjoint Senior Fellow
The Sir Peter MacCallum Department of Oncology
ORCID

0000-0002-8056-5348

Dr Mark Dowling

Honorary Conjoint Senior Fellow
The Sir Peter MacCallum Department of Oncology
90 Scholarly works
3 Projects

HIGHLIGHTS

  • 2026

    Journal article

    A Critical Review of Clinical Factors and Tools for Predicting Chimeric Antigen Receptor T-Cell Toxicities.
    DOI: 10.1016/j.jtct.2026.05.027
  • 2026

    Journal article

    Infections in the First 30 Days after Chimeric Antigen Receptor T-Cell Therapy in Patients Not Receiving Fluoroquinolone Prophylaxis.
    DOI: 10.1016/j.jtct.2026.03.040
  • 2026

    Journal article

    Time of infusion does not significantly impact outcomes following CAR T-cell therapy in large B-cell lymphoma
    DOI: 10.1182/blood.2025032307
  • 2026

    Journal article

    DEVELOPMENT AND CLINICAL DELIVERY OF AN AUSTRALIAN-MANUFACTURED CD19 CAR-T CELL THERAPY: THE PLATYPS STUDY
    DOI: 10.1016/j.jcyt.2026.102647
  • 2026

    Research grants (ARC, NHMRC, MRFF)

    Next Generation Cellular Immunotherapy for Multiple Myeloma and Beyond
  • 2026

    Research grants (other domestic)

    Development of a Novel Nanobody-Secreting CAR-T Cell for the Treatment of Multiple Myeloma
  • 2025

    Research grants (other domestic)

    Clinical, Laboratory and Radiological Predictive Factors for Safety and Efficacy of Chimeric Antigen Receptor (CAR) T-Cell Therapy in Australia: A Multi-Centre Real-World Study
Mark Dowling

RECENT SCHOLARLY WORKS